Inventor · disambiguated record
Michael Rosconi
Also filed as: ROSCONI MICHAEL
8 granted patents·7 pending applications·8 citations·filing 2019–2025
81Inventor score
Files withREGENERON PHARMA15
Top patents by PatentIndex Score
15 records- 0196US12180272B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2022·Granted Dec 31, 2024·2 cites·11 claims
- 0296US11708407B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2022·Granted Jul 25, 2023·2 cites·26 claims
- 0392US12391753B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Granted Aug 19, 2025·0 cites·22 claims
- 0491US12215148B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2020·Granted Feb 4, 2025·2 cites·25 claims
- 0591US2025333492A1Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0690US12331109B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Granted Jun 17, 2025·0 cites·23 claims
- 0787US11965020B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2023·Granted Apr 23, 2024·0 cites·24 claims
- 0887US2025289883A1Novel antigen binding molecule formatsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0986US11754569B2Methods for characterizing protein complexesREGENERON PHARMA·Filed 2019·Granted Sep 12, 2023·2 cites·20 claims
- 1078US12474349B2Methods for characterizing protein complexesREGENERON PHARMA·Filed 2023·Granted Nov 18, 2025·0 cites·18 claims
- 1178US2024167984A1Methods for detecting and determining protein structures and stability in fluids, including biological fluidsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1278US2024168018A1Methods for detecting and evaluating viruses and virus-like particlesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1367US2025035532A1Methodology to characterize empty-full ratio in crude aav samplesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1457US2024060978A1Isoelectric focusing-based enrichment of charge variant speciesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1549US2020369720A1Characterization of domain-specific charge variants of antibodiesREGENERON PHARMA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →